Logo image of ICHR

ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis

NASDAQ:ICHR - Nasdaq - KYG4740B1059 - Common Stock - Currency: USD

20.84  -0.15 (-0.71%)

After market: 18.67 -2.17 (-10.41%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ICHR. ICHR was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While ICHR seems to be doing ok healthwise, there are quite some concerns on its profitability. ICHR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ICHR was profitable.
ICHR had a positive operating cash flow in the past year.
In multiple years ICHR reported negative net income over the last 5 years.
In the past 5 years ICHR always reported a positive cash flow from operatings.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

With a Return On Assets value of -2.09%, ICHR is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -2.98%, ICHR is doing worse than 60.91% of the companies in the same industry.
Industry RankSector Rank
ROA -2.09%
ROE -2.98%
ROIC N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

With a Gross Margin value of 12.17%, ICHR is not doing good in the industry: 88.18% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ICHR has declined.
ICHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ICHR has more shares outstanding
The number of shares outstanding for ICHR has been increased compared to 5 years ago.
ICHR has a better debt/assets ratio than last year.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ICHR has an Altman-Z score of 2.91. This is not the best score and indicates that ICHR is in the grey zone with still only limited risk for bankruptcy at the moment.
ICHR has a Altman-Z score of 2.91. This is comparable to the rest of the industry: ICHR outperforms 50.91% of its industry peers.
ICHR has a debt to FCF ratio of 12.55. This is a negative value and a sign of low solvency as ICHR would need 12.55 years to pay back of all of its debts.
ICHR has a Debt to FCF ratio of 12.55. This is comparable to the rest of the industry: ICHR outperforms 50.91% of its industry peers.
ICHR has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.17, ICHR perfoms like the industry average, outperforming 48.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 12.55
Altman-Z 2.91
ROIC/WACCN/A
WACC9.41%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

ICHR has a Current Ratio of 3.34. This indicates that ICHR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ICHR (3.34) is comparable to the rest of the industry.
ICHR has a Quick Ratio of 1.49. This is a normal value and indicates that ICHR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ICHR (1.49) is worse than 70.91% of its industry peers.
Industry RankSector Rank
Current Ratio 3.34
Quick Ratio 1.49
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

ICHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.98%.
Measured over the past years, ICHR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.82% on average per year.
The Revenue has been growing slightly by 4.67% in the past year.
Measured over the past years, ICHR shows a small growth in Revenue. The Revenue has been growing by 6.46% on average per year.
EPS 1Y (TTM)-60.98%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%233.33%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%14.65%

3.2 Future

The Earnings Per Share is expected to grow by 86.61% on average over the next years. This is a very strong growth
ICHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.03% yearly.
EPS Next Y780.71%
EPS Next 2Y249.45%
EPS Next 3Y112.73%
EPS Next 5Y86.61%
Revenue Next Year16.24%
Revenue Next 2Y11.87%
Revenue Next 3Y9.3%
Revenue Next 5Y12.03%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 130.25, the valuation of ICHR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ICHR indicates a slightly more expensive valuation: ICHR is more expensive than 61.82% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.10. ICHR is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 14.79 indicates a correct valuation of ICHR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICHR indicates a somewhat cheap valuation: ICHR is cheaper than 80.00% of the companies listed in the same industry.
ICHR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.74.
Industry RankSector Rank
PE 130.25
Fwd PE 14.79
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ICHR.
The rest of the industry has a similar Price/Free Cash Flow ratio as ICHR.
Industry RankSector Rank
P/FCF 69.39
EV/EBITDA 31.85
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

ICHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ICHR's earnings are expected to grow with 112.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y249.45%
EPS Next 3Y112.73%

More info and screens

0

5. Dividend

5.1 Amount

ICHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ICHOR HOLDINGS LTD

NASDAQ:ICHR (5/5/2025, 8:17:45 PM)

After market: 18.67 -2.17 (-10.41%)

20.84

-0.15 (-0.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners95.77%
Inst Owner Change-1.1%
Ins Owners1.54%
Ins Owner Change-1.67%
Market Cap710.85M
Analysts80
Price Target38.76 (85.99%)
Short Float %2.81%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.29%
Min EPS beat(2)-9.51%
Max EPS beat(2)10.09%
EPS beat(4)2
Avg EPS beat(4)-1111.94%
Min EPS beat(4)-4511.76%
Max EPS beat(4)63.4%
EPS beat(8)4
Avg EPS beat(8)-539.82%
EPS beat(12)6
Avg EPS beat(12)-358.69%
EPS beat(16)8
Avg EPS beat(16)-269.14%
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-1.73%
Max Revenue beat(2)1.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.73%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)0%
Revenue beat(12)7
Avg Revenue beat(12)0.07%
Revenue beat(16)8
Avg Revenue beat(16)-0.43%
PT rev (1m)-11.28%
PT rev (3m)-9.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.37%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)12.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.61%
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 130.25
Fwd PE 14.79
P/S 0.84
P/FCF 69.39
P/OCF 25.5
P/B 1.02
P/tB 2.35
EV/EBITDA 31.85
EPS(TTM)0.16
EY0.77%
EPS(NY)1.41
Fwd EY6.76%
FCF(TTM)0.3
FCFY1.44%
OCF(TTM)0.82
OCFY3.92%
SpS24.89
BVpS20.47
TBVpS8.88
PEG (NY)0.17
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.09%
ROE -2.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.17%
FCFM 1.21%
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score4
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 12.55
Debt/EBITDA 5.24
Cap/Depr 57.36%
Cap/Sales 2.08%
Interest Coverage N/A
Cash Conversion 120.67%
Profit Quality N/A
Current Ratio 3.34
Quick Ratio 1.49
Altman-Z 2.91
F-Score4
WACC9.41%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.98%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%233.33%
EPS Next Y780.71%
EPS Next 2Y249.45%
EPS Next 3Y112.73%
EPS Next 5Y86.61%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%14.65%
Revenue Next Year16.24%
Revenue Next 2Y11.87%
Revenue Next 3Y9.3%
Revenue Next 5Y12.03%
EBIT growth 1Y29.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year372.64%
EBIT Next 3Y49.37%
EBIT Next 5Y57.86%
FCF growth 1Y-75.69%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-51.62%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%